Legal News

The U.S. Department of Justice filed a notice on May 1 to appeal New York Judge Edward R. Korman’s decision last month to make levonorgestrel-based emergency contraceptives available without a prescription and without point-of-sale or age restrictions.

Last month's judicial ruling that all women of any age have non-Rx access to the drug remains an issue

Legislation would create a new class of drug makers and strengthen FDA oversight

Repercussions of PBM consolidation

The new organization begins by defining its terms

Effective communication is the keystone of pharmacy ethics in daily practice

Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?

Ruling clears obstacles judge said were politically influenced

The IMS report tracked impact of care on Managed Medicaid beneficiaries in Kentucky, New Jersey, New York, and Ohio since 2011 in three therapeutic areas: antipsychotics, diabetes agents, and respiratory medications

The U.S. Supreme Court will have to decide whether reverse payments, also known as “pay-for-delay settlements,” between branded and generic drug companies are anticompetitive and violate U.S. antitrust law.

Politicians worried about patient medication shipments challenge the U.S. Postal Service over its recent decision to eliminate Saturday letter deliveries

How to drive up medication costs 10% to 20%

OCR issues its final HITECH rule before compliance date of September 23, 2013

FDA is receiving insufficient information and has limited authority to enforce REMS, says OIG report

A look at what's going on with the Continuing Professional Development initiative from ACPE.

A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.

The fungal meningitis outbreak can serve as a reminder of the need for risk management.

The Federal Trade Commission recently settled with a Puerto Rican pharmacy network that was allegedly engaging in noncompetitive behavior.

An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law.

Medication errors can't be completely eliminated, but can CQI programs keep them to a minimum?

Federal agencies have fined an LTC provider $50 million for improperly dispensing controlled substances.

What has staved off even higher levels of ongoing shortages is that drugmakers are reporting potential shortages much more often and FDA is using various tactics to prevent them from becoming reality.

That the Supreme Court upheld the Affordable Care Act bodes well for the generic drug market, which is already growing by leaps and bounds annually. Industry consultants expect ACA implementation to notably benefit retail pharmacists, PBMs, and drug wholesalers.

DEA published its interim final rule on e-prescribing for controlled substances (EPCS) more than two years ago. While vendors work toward compliance, nationwide deployment of EPCS can only occur once both state and federal laws are aligned in all jurisdictions.